Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.

Jank, Paul; Gehlhaar, Claire; Lederer, Bianca; Fontanella, Caterina; Schneeweiss, Andreas; Karn, Thomas; Marmé, Frederik; Sinn, Hans-Peter et al. · PLoS One · 2021

Where this comes from

Record sourced from PubMed, PMID 34469495.
Also identified by DOI 10.1371/journal.pone.0257142 and PMC identifier 8409660.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0238021.].

Read the full text

View on PubMed · Publisher (DOI)